Navigation Links
Genetic profile predicts which bladder cancer patients will benefit from early chemotherapy
Date:5/30/2014

CHICAGO, IL (May 30, 2014)Three genetic changes can predict whether a patient will benefit from chemotherapy before surgery to remove bladder cancer, according to new findings presented by Fox Chase Cancer Center researchers during the 50th Annual Meeting of the American Society of Clinical Oncology.

During the study, 36 patients with muscle-invasive bladder cancer received chemotherapy before surgery, consisting of an accelerated regimen of methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC). By the time surgery rolled around, 14 patients appeared cancer-free. All but one of these patients carried mutations in at least one of three specific genes; none of these mutations were present in any of the people who still harbored traces of cancer after AMVAC.

These results suggest that doctors may one day sequence patients' tumors for the presence of these three mutations, to determine who will likely benefit most from chemotherapy before surgery, said Elizabeth R. Plimack, MD, Attending Physician in the Department Medical Oncology at Fox Chase.

"The purpose of the study is to find ways to identify patients who are likely to respond to early chemotherapy," said Dr. Plimack. "For those patients who won't benefit from it, we can send them directly to surgery to save time. But if they carry at least one of these mutations, we can treat them knowing they are likely to respond," she noted.

To uncover a genetic pattern that predicted responses to AMVAC, Dr. Plimack and her colleagues in collaboration with Foundation Medicine sequenced 287 cancer-related genes in tissue samples taken before patients underwent chemotherapy. The analysis clearly landed on three genes, all associated with repairing damaged DNA, carried by all but one of the people who benefited from chemotherapy. To see such a clear distinction between the genetic profiles of responding and non-responding tumors is remarkable, Dr. Plimack added. "It is unusual
'/>"/>

Contact: Diana Quattrone
Diana.Quattrone@fccc.edu
215-815-7828
Fox Chase Cancer Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. IntegraGen launches ARISk test, a genetic screening tool for autism in high-risk children
2. 2 genetic deletions in human genome linked to the development of aggressive prostate cancer
3. Head, Body Lice Are Genetically Very Similar
4. Certain Genetic Regions May Be Tied to Osteoporosis
5. Study of half siblings provides genetic clues to autism
6. Genetic variants, tobacco exposure and lung cancer risk
7. Research Gets Closer to Genetic Roots of Glaucoma
8. Moffitt researcher awarded GE grant to develop tool to detect breast cancer metastasis genetic risks
9. Genetically modified T cell therapy shown to be safe, lasting in decade-long study of HIV patients
10. Some women may be genetically predisposed to smoking-related hot flashes
11. Genetic abnormalities in benign or malignant tissues predict relapse of prostate cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... is a famous wedding dress company offering many trendy designs. ... Facebook, Twitter, and Pinterest. The fans will have an opportunity ... every week. , Moreover, the company has extended its 2015 ... homepage for more information. , Angelweddingdress is a ...
(Date:1/22/2015)... 22, 2015 Juvent Sports ( http://www.juventsports.com ... 2015 PGA Merchandise Show to bestow a Juvent Sports ... amateur golfer, Arlene McKitrick. The award commemorated and congratulated ... tournament win. She won her first amateur tournament in ...
(Date:1/22/2015)... Oceanside,CA (PRWEB) January 22, 2015 For over 20 ... the Oceanside and Vista area has treated just about ... other personal injury circumstances. And for those same twenty-plus years, ... victims of all those injuries with the best possible doctor. ...
(Date:1/22/2015)... Jolla, Calif. (PRWEB) January 22, 2015 ... Assemblymembers Susan Bonilla (D-Concord) and Kristin Olsen (R-Modesto) ... for their leadership in advancing biotechnology, biomedical science, ... Bonilla and Olsen each received the “2014 Life ...
(Date:1/22/2015)... January 22, 2015 Payday lending practices ... communities and cause financial distress to the states that ... at Howard University’s Center on Race and Wealth. , ... economic activity, payday loans at the same time substantially ...
Breaking Medicine News(10 mins):Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2
... Wales health department in Australia chose to understand the relationship ... ,The study conducted over three years covered a gamut of ... that a greater proportion of people born in Italy and ... Zealanders were physically more active than other ethnic groups. People ...
... condition in children. Children suffering from insomnia //and hypersomnia ... normal sleep. ,Sleep-disturbed children, with both insomnia ... than those with either insomnia or hypersomnia. ... and colleagues of the University of Pittsburgh, 553 children ...
... lawsuits can significantly slow or halt science's ability ... //factors produced by industry, a team of scientists ... ,The authors caution that litigation's effects could seriously ... a wide variety of diseases, including Parkinson's disease, ...
... discovered that a tiny piece of genetic code apparently goes ... gets there under its own internal code. ,MicroRNAs, already ... gum up larger strands of RNA that carry instructions for ... are, says Joshua Mendell, M.D., Ph.D., an assistant professor in ...
... joining a sugar to a short-chain fatty acid compound, ... that kills cancer // cells in lab tests. The ... been tested on animals or humans. Nevertheless, they believe ... deadly disease. ,“For a long time, ...
... Preston Mason and colleagues at Elucida Research has ... in nature, shows significant promise as a viable ... disease based on its exceptional antioxidant properties in ... and anecdotal human data, the results of the ...
Cached Medicine News:Health News:Fast-Multiplying Lawsuits Can Stymie Medical Science, Authors Warn 2Health News:Fast-Multiplying Lawsuits Can Stymie Medical Science, Authors Warn 3Health News:Renegade RNA: Clues to Cancer and Normal Growth 2Health News:Hybrid Molecule Causes Cancer Cells to Self-Destruct 2Health News:Hybrid Molecule Causes Cancer Cells to Self-Destruct 3Health News:Study Finds Astaxanthin Is Potent Inhibitor of Oxidation in Cell Membrane Model 2Health News:Study Finds Astaxanthin Is Potent Inhibitor of Oxidation in Cell Membrane Model 3
(Date:1/23/2015)... BOSTON , January 23, 2015 ... development company, is delighted to announce that the Malcolm ... Miles Congreve (Vice President of Chemistry), Fiona ... Weir (Chief Executive Officer and co-founder) for the seminal ...
(Date:1/22/2015)... is pleased to announce the appointment of Dr. ... Biochemistry. Scott joins the company after previous scientific leadership positions ... course of his nearly 20 year career in therapeutics ... recognized thought leader in the biosensor field and particularly ...
(Date:1/22/2015)... /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), ... for cardiovascular disease and overall health is pleased to provide ... and its outlook for 2015 from the CEO, Mr. ... We would like to take this opportunity to share with ...
Breaking Medicine Technology:Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4BiOptix Expands Leadership Team with the Appointment of Dr. Scott Klakamp as Vice President of Chemistry and Biochemistry 2Pivotal Therapeutics: Year in Review and CEO Update 2Pivotal Therapeutics: Year in Review and CEO Update 3Pivotal Therapeutics: Year in Review and CEO Update 4Pivotal Therapeutics: Year in Review and CEO Update 5Pivotal Therapeutics: Year in Review and CEO Update 6Pivotal Therapeutics: Year in Review and CEO Update 7
... ... ... ... ...
... ... ... ... ...
Cached Medicine Technology:DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 2DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 3DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 4DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 5DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 6DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 7DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 8DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 9DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 10DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 11DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 12DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 13DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 14DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 15Carl Zeiss Chooses AT&T as Global Provider For Comprehensive Communications Services 2Carl Zeiss Chooses AT&T as Global Provider For Comprehensive Communications Services 3Carl Zeiss Chooses AT&T as Global Provider For Comprehensive Communications Services 4Carl Zeiss Chooses AT&T as Global Provider For Comprehensive Communications Services 5Carl Zeiss Chooses AT&T as Global Provider For Comprehensive Communications Services 6
PDA application containing all 7,000+ Physicians' Current Procedural Terminology codes developed by the American Medical Association....
Comprehensive and structured clinical resource with access to more than 1,000 medical and surgical conditions, fully indexed with more than 7,500 items and medications....
... with BD Xstar Blade includes a specially ... blade in prodedure and handling. The ... grind-less process for manufacturing surgical blades. ... consistency. The arch style, single-bevel geometry ...
Product includes all 15 Lexi-Comps databases. Includes Lexi-drugs, the official reference of the American Pharmacists Association and the National Professional Society of Pharmacists....
Medicine Products: